FDA authorizes the emergency use of Gilead's remdesivir in Covid-19 patients after researchers reported it shortened recovery times
WASHINGTON—The Food and Drug Administration authorized the emergency use of the drug remdesivir in Covid-19 patients after researchers reported that it shortened the recovery times in people who have fallen ill from the new coronavirus.
The FDA action limits the use of the drug, produced by Gilead Sciences Inc., for only through the duration of the pandemic, but health regulators could grant full approval if more benefits emerge from a large study by the National Institute of Allergy and Infectious Diseases and other clinical...
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes emergency use of coronavirus drug remdesivirThe FDA has issued an emergency use authorization for remdesivir to help patients get quicker access to the first antiviral showing promise against Covid-19 infections
Read more »
FDA authorizes remdesivir drug as emergency treatment for COVID-19The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
Read more »
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
Read more »
Fauci says leak concerns fueled his White House revelation of Gilead drug resultsConcerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.
Read more »
Gilead CEO on remdesivir: manufacturing, pricing for coronavirus drug - Business InsiderGilead plans to spend up to $1 billion to ramp up manufacturing of its coronavirus treatment, but execs dodged Wall Street's questions about turning a profit
Read more »
Maker of coronavirus trial drug aims for wide distribution: Gilead CEOGilead Sciences , which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O'Day said on Friday.
Read more »